Pfizer Inc (PFE)
Net profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 8,031,000 | 2,119,000 | 31,372,000 | 21,979,000 | 7,020,000 |
| Revenue | US$ in thousands | 63,627,000 | 58,496,000 | 100,330,000 | 81,288,000 | 41,908,000 |
| Net profit margin | 12.62% | 3.62% | 31.27% | 27.04% | 16.75% |
December 31, 2024 calculation
Net profit margin = Net income ÷ Revenue
= $8,031,000K ÷ $63,627,000K
= 12.62%
Based on the provided data, Pfizer Inc's net profit margin has fluctuated over the five-year period from December 31, 2020, to December 31, 2024. The net profit margin, which represents the percentage of revenue that translates into profit after accounting for all expenses, stood at 16.75% in 2020 and showed a significant improvement to 27.04% in 2021. The trend continued positively as it increased to 31.27% in 2022, reflecting strong profitability.
However, there was a notable decline in the net profit margin in 2023 to 3.62%, indicating a decrease in profitability potentially due to various factors such as higher expenses or lower revenue. Subsequently, there was a recovery in 2024 with the net profit margin rising to 12.62%, but it remained below the levels seen in 2021 and 2022.
Overall, Pfizer Inc's net profit margin has shown variability over the five-year period, with fluctuations reflecting changes in the company's financial performance and efficiency in managing costs and revenue generation. It may be important for stakeholders to further analyze the reasons behind the fluctuations to assess the company's overall financial health and sustainability.
Peer comparison
Dec 31, 2024